Crestor Class Action Lawsuit

Did you know these deadly side effects were evident before Crestor was approved by the Food and Drug Administration? That's right, Crestor was approved by the Food and Drug Administration approval in August 2003, after a delay because of safety concerns. During FDA studies seven cases of the potentially fatal, muscle-destroying condition rhabdomyolysis occurred.

These studies also linked Crestor with cases of kidney abnormalities not seen with other statins. The FDA decided to approve Crestor but at lower dosages. However, records from the FDA and health agencies in Canada and Britain show life-threatening side effects occur even at those lower doses.

Similar to another statin cholesterol drug, Baycol, which was removed from the market, Crestor (Rosuvastatin Calcium) can cause or contribute to causing rhabdomyolysis, a condition in which muscle cells are damaged causing release of myoglobin, which in turn causes kidney damage and can be fatal. Symptoms of rhabdomyolysis include dark or red urine, muscle tenderness, muscle or generalized weakness, muscle stiffness, joint pain, fatigue and, sometimes, seizures.

Crestor also can cause liver damage and liver failure leading to transplant and death. Common symptoms of liver damage include:

  • Yellow eyes;
  • Jaundice;
  • Nausea;
  • Abdominal pain;
  • Clay-colored stool; and
  • Dark urine.

Are you one of many who may have been injured by the Crestor drug? You may consider starting or joining a class action. Class actions are an effective way to level the playing field against AstraZeneca Pharmaceuticals, LP, while keeping the individual plaintiff costs down to a minimum.

Don't delay. Statutes of limitation do apply and any delay on your part could adversely affect your potential claim. Contact a Crestor attorney now to determine if a class action is the best course of action for you.

Search LawInfo's Crestor Resources